StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2022 - 05 - 25
2
2022 - 05 - 24
1
2021 - 10 - 18
1
2021 - 06 - 16
2
2021 - 04 - 19
2
Sector
Health technology
8
Tags
Acquisition
1
Afrezza
3
Agreement
1
Alliances
1
Application
6
Approval
1
Aviptadil
2
Biocapital
2
Bioconnect 2021 conference
1
Bioforest
1
Biosimilar
1
Biotech
1
Biotech-beach
7
Biotechnology
5
Clinical-trials-phase-iii
2
Collaboration
2
Conference
36
Corporation
30
Device
3
Diabetes
12
Disease
4
Drug
12
Earnings
6
Europe
2
Events
12
Fda
8
Fda-approvals
2
Financial
8
Financial results
9
Global
4
Health
2
Hypertension
3
Insulin
6
Life science
3
Living
2
Market
4
Mergers-and-acquisitions
2
Milestone
3
N/a
62
New drug
7
People
2
Pharma
4
Pharmaceutical
2
Potential
2
Presentation
3
Product-news
2
Rare
2
Regulatory
2
Research
3
Respiratory
4
Results
20
Study
4
Technology
2
Thc
2
Therapeutics
5
Therapy
2
Today
2
Treatment
3
Trial
2
Year
2
Entities
22nd century group, inc
10
Abbott laboratories
79
Abbvie inc.
42
Acer therapeutics inc.
12
Adma biologics inc
18
Amgen inc.
23
Amneal pharmaceuticals, inc.
15
Ani pharmaceuticals, inc.
17
Apyx medical corporation
12
Aquestive therapeutics, inc.
15
Ardelyx, inc.
11
Arrival
10
Astellas pharma inc
17
Avenue therapeutics, inc.
10
Becton, dickinson and company
13
Beigene, ltd.
16
Biogen inc.
32
Biomarin pharmaceutical inc.
10
Biontech se
24
Bluebird bio, inc.
13
Boston scientific corporation
11
Brainstorm cell therapeutics inc.
14
Bristol-myers squibb company
20
Coherus biosciences, inc.
23
Eagle pharmaceuticals, inc.
11
Eli lilly and company
71
Eyenovia, inc.
13
Fortress biotech, inc.
14
Gilead sciences, inc.
21
Glaxosmithkline plc
14
Incyte corporation
23
Inhibikase therapeutics, inc.
10
Ionis pharmaceuticals, inc.
13
Jaguar health, inc.
16
Johnson & johnson
226
Medtronic plc
28
Merck & company, inc.
36
Mesoblast limited
15
Moderna, inc.
13
Novartis ag
28
Novavax, inc.
11
Novo nordisk a/s
11
Ocugen, inc.
15
Orange
63
Perrigo company
90
Pfizer, inc.
74
Reata pharmaceuticals, inc.
12
Regeneron pharmaceuticals, inc.
50
Sanofi
236
Seagen inc.
10
Soligenix, inc.
14
Sorrento therapeutics, inc.
21
T2 biosystems, inc.
14
Takeda pharmaceutical company limited
17
Teva pharmaceutical industries ltd
22
Thermo fisher scientific inc
16
Tonix pharmaceuticals holding corp.
12
Verrica pharmaceuticals inc.
13
Vertex pharmaceuticals incorporated
14
Veru inc.
14
Symbols
MNKD
8
OMER
1
UTHR
5
Exchanges
Nasdaq
8
Crawled Date
2022 - 05 - 25
2
2022 - 05 - 24
1
2021 - 10 - 18
1
2021 - 06 - 16
2
2021 - 04 - 19
2
Crawled Time
10:00
2
11:00
3
15:00
1
16:00
2
Source
www.biospace.com
5
www.globenewswire.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Fda
entities :
Mannkind corporation
save search
United Therapeutics Gets FDA Green Light For First Inhaled Hypertension Therapeutic
Published:
2022-05-25
(Crawled : 16:00)
- biospace.com/
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
2.5%
|
O:
0.0%
H:
6.0%
C:
5.0%
fda
hypertension
therapeutics
United Therapeutics Gets FDA Green Light For First Inhaled Hypertension Thera...
Published:
2022-05-25
(Crawled : 16:00)
- biospace.com/
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
2.5%
|
O:
0.0%
H:
6.0%
C:
5.0%
fda
hypertension
therapeutics
MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™
Published:
2022-05-24
(Crawled : 11:00)
- biospace.com/
UTHR
|
$237.16
0.79%
0.78%
480K
|
Health Technology
|
23.26%
|
O:
10.26%
H:
4.52%
C:
4.01%
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
9.92%
|
O:
12.33%
H:
5.25%
C:
-4.53%
technosphere
platform
fda
FDA Serves Omeros, MannKind-United and Revance with CRLs
Published:
2021-10-18
(Crawled : 15:00)
- biospace.com/
OMER
|
$3.22
-3.59%
-3.73%
430K
|
Health Technology
|
-57.23%
|
O:
-21.64%
H:
0.49%
C:
-7.35%
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
-22.79%
|
O:
-18.08%
H:
0.69%
C:
-4.37%
fda
MannKind and United Therapeutics Achieve a Major Milestone in the Development of Tyvaso DPI™ With New Drug Application Acceptance From the FDA
Published:
2021-06-16
(Crawled : 11:00)
- globenewswire.com
UTHR
|
$237.16
0.79%
0.78%
480K
|
Health Technology
|
31.86%
|
O:
0.61%
H:
2.95%
C:
2.18%
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
0.0%
|
O:
3.17%
H:
8.27%
C:
2.36%
new drug
fda
drug
application
milestone
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review
Published:
2021-06-16
(Crawled : 10:00)
- prnewswire.com
UTHR
|
$237.16
0.79%
0.78%
480K
|
Health Technology
|
31.86%
|
O:
0.61%
H:
2.95%
C:
2.18%
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
0.0%
|
O:
3.17%
H:
8.27%
C:
2.36%
new drug
fda
fda acceptance
drug
application
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
Published:
2021-04-19
(Crawled : 11:00)
- biospace.com/
UTHR
|
$237.16
0.79%
0.78%
480K
|
Health Technology
|
15.5%
|
O:
0.6%
H:
0.11%
C:
-0.54%
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
-1.91%
|
O:
-0.24%
H:
1.68%
C:
-0.24%
new drug
fda
drug
milestone
United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA
Published:
2021-04-19
(Crawled : 10:00)
- prnewswire.com
UTHR
|
$237.16
0.79%
0.78%
480K
|
Health Technology
|
15.5%
|
O:
0.6%
H:
0.11%
C:
-0.54%
MNKD
|
$4.08
-0.49%
-0.49%
1.3M
|
Health Technology
|
-1.91%
|
O:
-0.24%
H:
1.68%
C:
-0.24%
new drug
fda
drug
submission
application
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.